JP2008522981A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008522981A5 JP2008522981A5 JP2007544636A JP2007544636A JP2008522981A5 JP 2008522981 A5 JP2008522981 A5 JP 2008522981A5 JP 2007544636 A JP2007544636 A JP 2007544636A JP 2007544636 A JP2007544636 A JP 2007544636A JP 2008522981 A5 JP2008522981 A5 JP 2008522981A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutical composition
- hydrogen
- aryl
- aralkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63436604P | 2004-12-07 | 2004-12-07 | |
| US60/634,366 | 2004-12-07 | ||
| US65593005P | 2005-02-23 | 2005-02-23 | |
| US60/655,930 | 2005-02-23 | ||
| PCT/US2005/044451 WO2006063154A1 (en) | 2004-12-07 | 2005-12-07 | Composition for proteasome inhibition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008522981A JP2008522981A (ja) | 2008-07-03 |
| JP2008522981A5 true JP2008522981A5 (https=) | 2008-10-02 |
| JP4990155B2 JP4990155B2 (ja) | 2012-08-01 |
Family
ID=36143200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007544636A Expired - Lifetime JP4990155B2 (ja) | 2004-12-07 | 2005-12-07 | プロテアソームを阻害するための組成物 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7737112B2 (https=) |
| EP (3) | EP2261236B1 (https=) |
| JP (1) | JP4990155B2 (https=) |
| KR (1) | KR101299821B1 (https=) |
| CN (2) | CN101180071A (https=) |
| AT (1) | ATE499109T1 (https=) |
| AU (1) | AU2005313975B2 (https=) |
| CA (1) | CA2589921C (https=) |
| CY (1) | CY1111489T1 (https=) |
| DE (1) | DE602005026556D1 (https=) |
| DK (1) | DK1819353T3 (https=) |
| ES (2) | ES2408216T3 (https=) |
| HU (1) | HUE027850T2 (https=) |
| IL (1) | IL183607A (https=) |
| PL (3) | PL2260835T3 (https=) |
| PT (3) | PT2260835E (https=) |
| WO (1) | WO2006063154A1 (https=) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8198270B2 (en) * | 2004-04-15 | 2012-06-12 | Onyx Therapeutics, Inc. | Compounds for proteasome enzyme inhibition |
| US8129346B2 (en) | 2004-04-15 | 2012-03-06 | Onyx Therapeutics, Inc. | Compounds for enzyme inhibition |
| EP2030981B1 (en) * | 2004-05-10 | 2014-07-09 | Onyx Therapeutics, Inc. | Compounds for proteasome enzyme inhibition |
| US9034846B2 (en) * | 2004-10-10 | 2015-05-19 | Universite De Liege | Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases |
| MY171061A (en) * | 2005-11-09 | 2019-09-24 | Onyx Therapeutics Inc | Compounds for enzyme inhibition |
| CA2657213C (en) | 2006-06-19 | 2017-01-03 | Proteolix, Inc. | Peptide epoxyketones for proteasome inhibition |
| KR20170125413A (ko) | 2007-10-04 | 2017-11-14 | 오닉스 세라퓨틱스, 인크. | 결정형 펩티드 에폭시 케톤 프로테아제 저해제 및 아미노산 케토-에폭시드의 합성 |
| US7635773B2 (en) | 2008-04-28 | 2009-12-22 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions |
| EA201170527A1 (ru) * | 2008-10-01 | 2011-10-31 | Др. Редди'С Лабораторис Лтд. | Фармацевтические композиции, включающие соединения бороновой кислоты |
| EP3090737A1 (en) * | 2008-10-21 | 2016-11-09 | Onyx Therapeutics, Inc. | Combination therapy with peptide epoxyketones |
| TWI504598B (zh) | 2009-03-20 | 2015-10-21 | Onyx Therapeutics Inc | 結晶性三肽環氧酮蛋白酶抑制劑 |
| EP2238973A1 (en) * | 2009-04-07 | 2010-10-13 | Cephalon France | Lyophilized preparations of proteasome inhibitors |
| PL2434886T3 (pl) | 2009-05-29 | 2020-05-18 | Cydex Pharmaceuticals, Inc. | Kompozycje do wstrzykiwania melfalanu zawierające pochodną cyklodekstryny i sposoby ich wytwarzania i stosowania |
| US11020363B2 (en) | 2009-05-29 | 2021-06-01 | Cydex Pharmaceuticals, Inc. | Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same |
| US8853147B2 (en) * | 2009-11-13 | 2014-10-07 | Onyx Therapeutics, Inc. | Use of peptide epoxyketones for metastasis suppression |
| EP2542238B1 (en) | 2010-03-01 | 2015-08-12 | Onyx Therapeutics, Inc. | Compounds for immunoproteasome inhibition |
| NZ602872A (en) | 2010-04-07 | 2014-05-30 | Onyx Therapeutics Inc | Crystalline peptide epoxyketone immunoproteasome inhibitor |
| EP2806877B2 (en) | 2012-01-23 | 2025-01-29 | Sage Therapeutics, Inc. | Neuroactive steroid formulations comprising a complex of allopregnanolone and sulfobutyl ether beta-cyclodextrin |
| WO2013123254A1 (en) | 2012-02-15 | 2013-08-22 | Cydex Pharmaceuticals, Inc. | Manufacturing process for cyclodextrin derivatives |
| RU2615385C2 (ru) | 2012-02-28 | 2017-04-04 | Сидекс Фармасьютикалс, Инк. | Композиции алкилированного циклодекстрина и способы их получения и применения |
| US20150038541A1 (en) * | 2012-03-19 | 2015-02-05 | Aposignal Bioscience Llc | Composition and methods for cell modulation |
| MY196510A (en) * | 2012-05-08 | 2023-04-18 | Onyx Therapeutics Inc | Cylodextrin Complexation Methods for Formulating Peptide Proteasome Inhibitors |
| SG11201407337QA (en) | 2012-05-08 | 2014-12-30 | Onyx Therapeutics Inc | Cyclodextrin complexation methods for formulating peptide proteasome inhibitors |
| US20140105921A1 (en) | 2012-07-09 | 2014-04-17 | Onyx Therapeutics, Inc. | Prodrugs of Peptide Epoxy Ketone Protease Inhibitors |
| EP2874605A1 (en) * | 2012-07-18 | 2015-05-27 | Onyx Therapeutics, Inc. | Liposomal compositions of epoxyketone-based proteasome inhibitors |
| CN109180780B (zh) * | 2012-07-26 | 2022-03-18 | 圣特莱国际公司 | 多肽环氧酮化合物 |
| WO2014018807A1 (en) * | 2012-07-26 | 2014-01-30 | Centrax International, Inc. | Peptide epoxyketone compounds |
| CA2881999A1 (en) * | 2012-08-14 | 2014-02-20 | Abdelmalik Slassi | Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitors |
| US9636376B2 (en) | 2012-09-11 | 2017-05-02 | Innopharma, Inc. | Stable compositions of peptide epoxy ketones |
| KR102112119B1 (ko) | 2012-10-22 | 2020-05-19 | 사이덱스 파마슈티칼스, 인크. | 알킬화된 시클로덱스트린 조성물 및 이의 제조 및 사용 방법 |
| PL2925299T3 (pl) * | 2012-11-30 | 2018-11-30 | Novartis Ag | Nowa kompozycja farmaceutyczna |
| US10076384B2 (en) | 2013-03-08 | 2018-09-18 | Symple Surgical, Inc. | Balloon catheter apparatus with microwave emitter |
| SG10201913777XA (en) | 2013-03-13 | 2020-03-30 | Sanofi Sa | Compositions comprising anti-cd38 antibodies and carfilzomib |
| EA030957B1 (ru) | 2013-03-14 | 2018-10-31 | Оникс Терапьютикс, Инк. | Дипептидные и трипептидные эпоксикетонные ингибиторы протеазы |
| AR095426A1 (es) | 2013-03-14 | 2015-10-14 | Onyx Therapeutics Inc | Inhibidores tripeptídicos de la epoxicetona proteasa |
| MX372671B (es) | 2013-07-19 | 2020-04-23 | Onyx Therapeutics Inc | Inhibidores de proteasoma de epoxicetona peptídica en combinacion con inhibidores de cinasa pim para el tratamiento de canceres. |
| KR102462240B1 (ko) * | 2014-07-14 | 2022-11-03 | 센트랙스 인터내셔널, 아이엔씨. | 효소 억제를 위한 에폭시케톤 화합물 |
| PT3183295T (pt) | 2014-08-22 | 2023-11-03 | Cydex Pharmaceuticals Inc | Composições de ciclodextrina alquilada fracionada e processos para preparação e utilização das mesmas |
| WO2016170489A1 (en) | 2015-04-24 | 2016-10-27 | Fresenius Kabi Oncology Ltd. | Pharmaceutical compositions of proteasome inhibitor |
| CN120204220A (zh) * | 2015-11-17 | 2025-06-27 | 博蔚医药生物科技股份有限公司 | 治疗及/或预防纤维性疾病的胺基萘醌化合物 |
| TWI759301B (zh) | 2016-05-24 | 2022-04-01 | 美商安美基公司 | 聚乙二醇化卡非佐米化合物 |
| ES2842575T3 (es) | 2016-08-05 | 2021-07-14 | Amgen Inc | Síntesis de (S)-2-amino-4-metil-1-((R)-2-metiloxiran-2-il)-pentan-1-ona y sales farmacéuticamente aceptables de la misma |
| WO2018038687A1 (en) | 2016-08-22 | 2018-03-01 | Mustafa Nevzat Ilaç Sanayii A.Ş. | Pharmaceutical formulations comprising a bortezomib-cyclodextrin complex |
| US10098890B2 (en) | 2016-10-29 | 2018-10-16 | Cipla Limited | Stable carfilzomib formulations |
| WO2018138557A1 (en) | 2017-01-24 | 2018-08-02 | Orbicular Pharmaceutical Technologies Pvt. Ltd. | Ready-to-use carfilzomib compositions |
| JP2020533382A (ja) | 2017-09-14 | 2020-11-19 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ | 癌の組合せ治療 |
| AU2018370019C1 (en) | 2017-11-16 | 2025-01-30 | Amgen Inc. | Stable compositions of pegylated carfilzomib compounds |
| US10537585B2 (en) | 2017-12-18 | 2020-01-21 | Dexcel Pharma Technologies Ltd. | Compositions comprising dexamethasone |
| US20250295771A1 (en) | 2022-05-11 | 2025-09-25 | Celgene Corporation | Methods and uses related to t cell therapy and production of same |
| WO2023220655A1 (en) | 2022-05-11 | 2023-11-16 | Celgene Corporation | Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy |
| WO2024097905A1 (en) | 2022-11-02 | 2024-05-10 | Celgene Corporation | Methods of treatment with t cell therapy and immunomodulatory agent maintenance therapy |
| WO2025035020A2 (en) | 2023-08-09 | 2025-02-13 | Amgen Inc. | Methods of using carfilzomib |
| WO2025092827A1 (zh) * | 2023-10-30 | 2025-05-08 | 上海汇伦医药股份有限公司 | 一种环氧类化合物及其应用 |
| EP4685151A1 (en) | 2024-07-24 | 2026-01-28 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Proteasome inhibitor |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
| US5135919A (en) * | 1988-01-19 | 1992-08-04 | Children's Medical Center Corporation | Method and a pharmaceutical composition for the inhibition of angiogenesis |
| US5441944A (en) * | 1989-04-23 | 1995-08-15 | The Trustees Of The University Of Pennsylvania | Substituted cyclodextrin sulfates and their uses as growth modulating agents |
| KR0166088B1 (ko) * | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| US5376645A (en) * | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| US5340736A (en) | 1991-05-13 | 1994-08-23 | The President & Fellows Of Harvard College | ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting |
| AU4499697A (en) | 1996-09-13 | 1998-04-02 | New York University | Method for treating parasitic diseases with proteasome inhibitors |
| US6046177A (en) * | 1997-05-05 | 2000-04-04 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| US5874418A (en) * | 1997-05-05 | 1999-02-23 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use |
| US6133248A (en) * | 1997-06-13 | 2000-10-17 | Cydex, Inc. | Polar drug of prodrug compositions with extended shelf-life storage and a method of making thereof |
| US6831099B1 (en) * | 1999-05-12 | 2004-12-14 | Yale University | Enzyme inhibition |
| CA2385958A1 (en) | 1999-10-20 | 2001-04-26 | Osteoscreen, Inc. | Inhibitors of proteasomal activity for stimulating bone and hair growth |
| AU2003219652A1 (en) * | 2002-01-08 | 2003-07-30 | Eisai Co. Ltd. | Eponemycin and epoxomicin analogs and uses thereof |
| CA2481306A1 (en) * | 2002-04-09 | 2003-10-23 | Greenville Hospital System | Metastasis modulating activity of highly sulfated oligosaccharides |
| US7232818B2 (en) | 2004-04-15 | 2007-06-19 | Proteolix, Inc. | Compounds for enzyme inhibition |
| US8129346B2 (en) * | 2004-04-15 | 2012-03-06 | Onyx Therapeutics, Inc. | Compounds for enzyme inhibition |
| EP2030981B1 (en) * | 2004-05-10 | 2014-07-09 | Onyx Therapeutics, Inc. | Compounds for proteasome enzyme inhibition |
-
2005
- 2005-12-07 PT PT101789980T patent/PT2260835E/pt unknown
- 2005-12-07 DK DK05853385.2T patent/DK1819353T3/da active
- 2005-12-07 EP EP10179422.0A patent/EP2261236B1/en not_active Expired - Lifetime
- 2005-12-07 EP EP10178998A patent/EP2260835B1/en not_active Expired - Lifetime
- 2005-12-07 EP EP05853385A patent/EP1819353B1/en not_active Expired - Lifetime
- 2005-12-07 PT PT101794220T patent/PT2261236E/pt unknown
- 2005-12-07 WO PCT/US2005/044451 patent/WO2006063154A1/en not_active Ceased
- 2005-12-07 PL PL10178998T patent/PL2260835T3/pl unknown
- 2005-12-07 ES ES10178998T patent/ES2408216T3/es not_active Expired - Lifetime
- 2005-12-07 AU AU2005313975A patent/AU2005313975B2/en active Active
- 2005-12-07 JP JP2007544636A patent/JP4990155B2/ja not_active Expired - Lifetime
- 2005-12-07 CA CA2589921A patent/CA2589921C/en not_active Expired - Lifetime
- 2005-12-07 CN CNA2005800478775A patent/CN101180071A/zh active Pending
- 2005-12-07 PL PL10179422T patent/PL2261236T3/pl unknown
- 2005-12-07 ES ES10179422.0T patent/ES2549763T3/es not_active Expired - Lifetime
- 2005-12-07 HU HUE10179422A patent/HUE027850T2/en unknown
- 2005-12-07 US US11/299,265 patent/US7737112B2/en active Active
- 2005-12-07 CN CN2012103747120A patent/CN102847136A/zh active Pending
- 2005-12-07 KR KR1020077015316A patent/KR101299821B1/ko not_active Expired - Lifetime
- 2005-12-07 AT AT05853385T patent/ATE499109T1/de active
- 2005-12-07 PT PT05853385T patent/PT1819353E/pt unknown
- 2005-12-07 PL PL05853385T patent/PL1819353T3/pl unknown
- 2005-12-07 DE DE602005026556T patent/DE602005026556D1/de not_active Expired - Lifetime
-
2007
- 2007-05-31 IL IL183607A patent/IL183607A/en active IP Right Grant
-
2011
- 2011-04-21 CY CY20111100410T patent/CY1111489T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008522981A5 (https=) | ||
| JP2008509166A5 (https=) | ||
| JOP20220069A1 (ar) | عوامل محللة لـ brd9 ثنائية الوظيفة وطرق لاستخدامها | |
| RU2397168C2 (ru) | Производные тиофена в качестве ингибиторов снк 1 | |
| ES2396595T3 (es) | Composición farmacéutica que contiene un derivado de pirazina y método de utilización de un derivado de pirazina en combinación | |
| UY28132A1 (es) | Derivados de pirrolopirimidina | |
| NO20090328L (no) | Nye forbindelser 385 | |
| MA31685B1 (fr) | Nouveaux derives de 6-triazolopyridazine-sulfanyl benzothiazole et benzimidazole, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met | |
| NO20072515L (no) | 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav | |
| JP2006509749A5 (https=) | ||
| NO20085060L (no) | Triazolpyrazinderivater anvendelige som anti-cancermidler | |
| MX2012001953A (es) | Composiciones fotosensibilizantes. | |
| CY1114803T1 (el) | Παραγωγα πυριμιδινο σουλφοναμιδιου ως ρυθμιστες υποδοχεων χημειοκινης | |
| RU2016135952A (ru) | Композиции ингибитора дофа-декарбоксилазы | |
| NO20070837L (no) | Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer. | |
| ATE386725T1 (de) | Heterocyclylverbindungen | |
| BR112013012057A2 (pt) | compostos de lipoil e seu uso para o tratamento de lesões isquêmicas | |
| RU2002100058A (ru) | Кристаллические производные 1-метилкарбапенема | |
| AR054129A1 (es) | Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7 | |
| BRPI0609783A8 (pt) | composto, utilização do mesmo, composição farmacêutica ou cosmética, e, utilização cosmética de um composto | |
| BR0311642A (pt) | Formulação de divalproex de sódio de liberação aumentada | |
| JP2016536372A5 (https=) | ||
| CL2020001156A1 (es) | Formulaciones de liberación prolongada para aplicaciones intra-articulares. | |
| BRPI0408270A (pt) | composição farmacêutica compreendendo ácido 5-metil-2-(2'cloro-6'-fluoroanilino)fenilacético | |
| FR2869615B1 (fr) | Derives de l'acide butanoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et leurs applications therapeutiques |